Security Snapshot

CalciMedica, Inc. - Common Stock (CALC) Institutional Ownership

CUSIP: 38942Q202

13F Institutional Holders and Ownership History from Q2 2023 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

30

Shares (Excl. Options)

3,655,018

Price

$6.59

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
CALC on Nasdaq
Shares outstanding
15,051,912
Price per share
$0.83
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
3,655,018
Total reported value
$24,086,565
% of total 13F portfolios
0%
Share change
+122,095
Value change
+$935,384
Number of holders
30
Price from insider filings
$0.83
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • CALC - CalciMedica, Inc. - Common Stock is tracked under CUSIP 38942Q202.
  • 30 institutions reported positions in Q4 2025.
  • 8 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 31 to 30 between Q3 2025 and Q4 2025.
  • Reported value moved from $10,948,007 to $24,086,565.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 30 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 38942Q202?
CUSIP 38942Q202 identifies CALC - CalciMedica, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of CalciMedica, Inc. - Common Stock (CALC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALAFI CAPITAL CO LLC 11% +17% $2,469,719 +$448,461 1,583,153 +22% Alafi Capital Company, LLC 22 Jul 2025
Avenue Venture Opportunities Fund II, L.P. 8.9% +31% $4,078,659 +$1,077,585 1,359,553 +36% Avenue Venture Opportunities Fund II, L.P. 01 Sep 2025
Chernett Jorey 7.9% $3,393,193 1,134,847 Chernett Jorey 24 Nov 2025
Soleus Private Equity Fund III, L.P. 7.5% $3,309,118 1,075,856 Soleus Capital Management, L.P. 30 Sep 2025
Aisling Capital V, LP 3.9% $1,180,323 781,671 Aisling Capital V, LP 03 Mar 2025
Bering Partners II GP, L.L.C. 5.8% $2,040,012 663,246 Bering Partners II, L.P. ("Bering II") 23 Jan 2024
Flynn James E 4.3% $4,304,937 653,253 Deerfield Mgmt, L.P. 06 Feb 2026
Stonepine Capital Management, LLC 4.6% -16% $949,295 -$170,674 628,672 -15% Stonepine Capital Management, LLC 31 Mar 2025

As of 31 Dec 2025, 30 institutional investors reported holding 3,655,018 shares of CalciMedica, Inc. - Common Stock (CALC). This represents 24% of the company’s total 15,051,912 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CalciMedica, Inc. - Common Stock (CALC) together control 24% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
DEERFIELD MANAGEMENT COMPANY, L.P. 8.6% 1,300,000 0% 0.11% $8,567,000
Soleus Capital Management, L.P. 4.5% 683,904 0% 0.19% $4,506,927
Aisling Capital Management LP 3.5% 521,114 0% 0.72% $3,434,141
VANGUARD GROUP INC 2.7% 407,801 +8.3% 0% $2,687,408
GEODE CAPITAL MANAGEMENT, LLC 0.66% 99,787 +0.95% 0% $657,595
RENAISSANCE TECHNOLOGIES LLC 0.59% 88,300 +26% 0% $581,897
BOOTHBAY FUND MANAGEMENT, LLC 0.51% 76,855 0.01% $506,474
ENVESTNET ASSET MANAGEMENT INC 0.42% 63,186 -18% 0% $416,396
MERITAGE PORTFOLIO MANAGEMENT 0.41% 61,539 0% 0.03% $405,542
Stonehage Fleming Financial Services Holdings Ltd 0.36% 53,703 0% 0.01% $353,902
PVG ASSET MANAGEMENT CORP 0.3% 45,830 0.64% $302,019
Summit Financial, LLC 0.24% 35,484 +41% 0% $233,840
180 WEALTH ADVISORS, LLC 0.21% 31,850 -25% 0.02% $209,892
Atria Investments, Inc 0.19% 28,781 -24% 0% $189,667
Cetera Investment Advisers 0.15% 22,290 -12% 0% $146,891
Sound View Wealth Advisors Group, LLC 0.13% 20,100 0% 0.01% $132,459
JANE STREET GROUP, LLC 0.13% 19,203 0% $126,548
J. Goldman & Co LP 0.13% 18,900 0% 0% $124,551
TritonPoint Partners, LLC 0.1% 15,119 0% 0.05% $99,634
MILLENNIUM MANAGEMENT LLC 0.1% 14,855 -57% 0% $97,894
FIRST MANHATTAN CO. LLC. 0.09% 13,226 0% 0% $87,159
NORTHERN TRUST CORP 0.08% 12,530 0% $82,573
Rockefeller Capital Management L.P. 0.07% 10,000 0% 0% $65,900
BANK OF AMERICA CORP /DE/ 0.06% 9,027 -0.06% 0% $59,488
UBS Group AG 0.01% 1,100 +6371% 0% $7,249

Institutional Holders of CalciMedica, Inc. - Common Stock (CALC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,655,018 $24,086,565 +$935,384 $6.59 30
2025 Q3 3,568,904 $10,948,007 -$154,104 $3.08 31
2025 Q2 3,726,254 $5,927,709 -$408,286 $1.60 30
2025 Q1 3,968,185 $7,492,715 -$1,152,368 $1.91 30
2024 Q4 4,262,920 $15,090,732 +$3,986,462 $3.54 28
2024 Q3 3,062,562 $13,557,086 +$372,349 $4.43 24
2024 Q2 2,974,014 $11,776,935 -$2,449,715 $3.96 20
2024 Q1 3,547,369 $14,756,693 +$12,607,257 $4.16 19
2023 Q4 516,778 $1,478,425 -$168,698 $2.86 10
2023 Q3 591,636 $1,561,335 -$597,671 $2.66 11
2023 Q2 678,595 $2,721,066 +$2,721,066 $4.01 12

Sponsored